CN Stock MarketDetailed Quotes
600222 Henan Taloph Pharmaceutical Stock
Watchlist
6.59
+0.02+0.30%
Trading 12/06 14:54 CST
6.62High6.45Low308.54KlotVolume
6.54Open6.57Pre Close202.28MTurnover5.38%Turnover RatioLossP/E (TTM)3.78BMarket Cap10.1752wk HighLossP/E (Static)573.89MShares4.8952wk Low2.61P/B3.78BFloat Cap17.94Historical High7.23Limit Up573.89MShs Float1.67Historical Low5.91Limit Down2.59%Amplitude147.51KlotAsk--Dividend TTM6.56Avg Price161.28KlotBid--Div YieldTTM100Lot Size
Henan Taloph Pharmaceutical Stock Key Stats
All
YOY

(Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | (Q3)2022/03/31 | (FY)2021/12/31 | (Q9)2021/09/30 | (Q6)2021/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 11.23%1.44B | 15.08%993.91M | 32.69%560.32M | 22.20%1.96B | 16.05%1.3B | 14.87%863.68M | 1.52%422.28M | 13.23%1.6B | 15.80%1.12B | 16.07%751.87M |
Operating revenue | 11.23%1.44B | 15.08%993.91M | 32.69%560.32M | 22.20%1.96B | 16.05%1.3B | 14.87%863.68M | 1.52%422.28M | 13.23%1.6B | 15.80%1.12B | 16.07%751.87M |
Other operating revenue | ---- | -73.64%1.32M | ---- | 441.56%15.33M | ---- | 531.22%5M | ---- | 102.22%2.83M | ---- | 510.52%792.63K |
Total operating cost | 11.17%1.47B | 19.45%1.04B | 35.51%558.03M | 29.79%1.99B | 22.04%1.33B | 19.78%867.32M | 8.93%411.8M | 10.37%1.54B | 15.34%1.09B | 16.68%724.09M |
Operating cost | 8.07%1.08B | 14.97%750.24M | 38.73%406.84M | 30.41%1.49B | 24.59%997.44M | 20.91%652.54M | 0.53%293.25M | 9.52%1.14B | 14.05%800.6M | 16.86%539.68M |
Operating tax surcharges | 16.56%6.31M | 12.99%4.57M | 23.16%2.44M | 6.70%8.42M | 2.17%5.41M | 11.33%4.04M | -14.09%1.98M | 6.51%7.9M | -1.33%5.3M | -15.21%3.63M |
Operating expense | 29.76%144.23M | 42.92%99.79M | 69.39%78.64M | 39.42%183.03M | 32.09%111.15M | 42.61%69.82M | 126.17%46.43M | 28.38%131.28M | 46.82%84.14M | 26.35%48.96M |
Administration expense | 9.31%104.04M | 21.01%75.76M | 1.22%33.24M | 16.32%134.48M | 10.63%95.17M | 2.15%62.61M | 12.30%32.84M | 5.95%115.61M | 6.30%86.02M | 10.67%61.29M |
Financial expense | -18.24%39.51M | -22.24%25.95M | -28.41%12.68M | -24.37%63.55M | -26.32%48.33M | -20.50%33.37M | -10.70%17.71M | 24.20%84.03M | 29.51%65.59M | 23.28%41.98M |
-Interest expense (Financial expense) | -11.91%38.31M | -20.81%24.66M | -30.42%12.12M | -22.91%58.91M | -22.01%43.49M | -16.21%31.14M | -12.35%17.42M | 6.44%76.42M | 21.78%55.76M | 7.94%37.16M |
-Interest Income (Financial expense) | 15.24%-1.7M | 31.44%-1.13M | 79.93%-164.52K | 28.21%-2.22M | -11.47%-2.01M | -29.33%-1.66M | -79.18%-819.61K | 58.27%-3.09M | 50.03%-1.8M | 63.47%-1.28M |
Research and development | 49.01%102.02M | 77.46%79.75M | 23.52%24.19M | 106.24%116.52M | 52.69%68.47M | 57.40%44.94M | 35.90%19.58M | -11.26%56.5M | -2.14%44.84M | 8.60%28.55M |
Credit Impairment Loss | 195.52%10.38M | 65.48%-2.45M | 134.45%2.3M | -139.75%-21.38M | -734.66%-10.86M | -469.78%-7.1M | -242.62%-6.66M | 28.43%-8.92M | 157.22%1.71M | 51.47%-1.25M |
Asset Impairment Loss | 31.02%-4.78M | -135.91%-4.41M | -31.61%-472.32K | 21.39%-17.31M | -3,265.96%-6.94M | -201.53%-1.87M | -101.33%-358.89K | -219.42%-22.02M | 216.77%219.06K | -24.13%1.84M |
Other net revenue | 166.74%10.43M | 17.40%-6.11M | 107.09%532.19K | -14.63%-36.86M | -674.20%-15.63M | -86.37%-7.4M | -3.15%-7.51M | -491.02%-32.15M | -121.28%-2.02M | -152.16%-3.97M |
Fair value change income | 107.64%592.89K | 79.91%-819.34K | 64.02%-968K | 19.60%-8.18M | 29.79%-7.76M | 52.87%-4.08M | 64.47%-2.69M | -526.76%-10.17M | -103.51%-11.06M | 1.10%-8.65M |
Invest income | -727.41%-3.98M | -484.71%-2.49M | -1,465.08%-1.74M | -179.66%-2.91M | -82.12%634.96K | -133.61%-425.35K | -74.11%127.34K | -21.62%3.66M | 1,135.96%3.55M | -7.30%1.27M |
-Including: Investment income associates | -171.03%-4.27M | -482.93%-2.5M | -597.61%-1.75M | -18,171.10%-6.07M | ---1.58M | ---429.23K | ---251.34K | -97.06%33.59K | ---- | ---- |
Asset deal income | 756.58%444.61K | 952.69%577.41K | --123.94K | ---67.72K | ---67.72K | ---67.72K | ---- | ---- | ---- | ---- |
Other revenue | -16.78%7.79M | -43.30%3.48M | -37.93%1.29M | 144.93%13M | 163.28%9.36M | 117.71%6.14M | 7.94%2.08M | -73.46%5.31M | -80.05%3.55M | -81.36%2.82M |
Operating profit | 53.25%-20.74M | -336.94%-48.26M | -5.38%2.82M | -298.77%-70.78M | -251.14%-44.36M | -146.38%-11.04M | -90.29%2.98M | 7.94%35.61M | -10.46%29.35M | -31.55%23.81M |
Add:Non operating Income | -93.29%8.56K | -97.15%527.5 | ---- | -98.12%132.19K | -98.18%127.66K | -99.74%18.53K | --544.91 | 34,984.69%7.02M | 4,063.73%7.02M | --7.01M |
Less:Non operating expense | -97.83%258.33K | -98.90%130.73K | -87.62%3.59K | -65.31%12.2M | 1,390.49%11.88M | 37,853.55%11.88M | 37.40%29.03K | 833.13%35.17M | -75.35%796.97K | -99.00%31.3K |
Total profit | 62.59%-20.99M | -111.26%-48.39M | -4.59%2.81M | -1,212.06%-82.85M | -257.75%-56.11M | -174.38%-22.91M | -90.37%2.95M | -74.52%7.45M | 19.70%35.57M | -2.76%30.8M |
Less:Income tax cost | -168.15%-1.47M | -535.09%-5.55M | -160.92%-475.91K | -1,162.42%-7.13M | -66.49%2.16M | -54.34%1.28M | -80.41%781.16K | -59.16%671.41K | 2.72%6.43M | -54.34%2.79M |
Net profit | FPtoL-19.52M | FPtoL-42.84M | 51.78%3.29M | SL-75.72M | SL-58.27M | SL-24.18M | -91.86%2.17M | -75.44%6.78M | 24.24%29.14M | 9.58%28M |
Net profit from continuing operation | 66.50%-19.52M | -77.17%-42.84M | 51.78%3.29M | -1,216.98%-75.72M | -299.99%-58.27M | -186.35%-24.18M | -91.86%2.17M | -75.44%6.78M | 24.24%29.14M | 9.58%28M |
Less:Minority Profit | -86.71%-2.59M | -460.18%-4.51M | -141.65%-394.19K | -556.52%-3.58M | -266.22%-1.39M | 52.54%1.25M | 29.41%-163.13K | 147.61%783.26K | 148.76%835.94K | 168.61%820.5K |
Net profit of parent company owners | 70.24%-16.93M | -50.72%-38.33M | 58.07%3.68M | -1,303.26%-72.14M | -300.99%-56.88M | -193.56%-25.43M | -91.33%2.33M | -79.50%6M | 12.45%28.3M | 1.62%27.18M |
Earning per share | ||||||||||
Basic earning per share | 70.33%-0.03 | -49.78%-0.0677 | 58.54%0.0065 | -1,299.07%-0.1283 | -300.60%-0.1011 | -193.20%-0.0452 | -91.48%0.0041 | -80.00%0.0107 | 9.33%0.0504 | -1.02%0.0485 |
Diluted earning per share | 70.33%-0.03 | -49.78%-0.0677 | 58.54%0.0065 | -1,299.07%-0.1283 | -300.60%-0.1011 | -193.20%-0.0452 | -91.48%0.0041 | -80.00%0.0107 | 9.33%0.0504 | -1.02%0.0485 |
Other composite income | 56.34%-60.52M | -3.07%-71.21M | -538.21%-29.62M | -166.29%-132.2M | -212.39%-138.62M | -133.00%-69.09M | -102.36%-4.64M | 3.65%199.43M | -33.73%123.34M | 209.34M |
Other composite income of parent company owners | 48.16%-60.52M | -28.20%-71.21M | -693.79%-29.62M | -168.82%-110.34M | -217.74%-116.76M | -133.00%-55.55M | -102.36%-3.73M | 3.65%160.34M | -33.73%99.17M | --168.31M |
Other composite income of minority owners | ---- | ---- | ---- | -155.93%-21.86M | -190.44%-21.86M | -133.00%-13.54M | -102.36%-909.64K | 3.65%39.09M | -33.73%24.18M | --41.03M |
Total composite income | 59.35%-80.05M | -22.28%-114.05M | -964.11%-26.33M | -200.83%-207.92M | -229.13%-196.89M | -139.30%-93.27M | -101.11%-2.47M | -6.27%206.21M | -27.25%152.48M | 828.81%237.34M |
Total composite income of parent company owners | 55.40%-77.45M | -35.27%-109.54M | -1,750.38%-25.94M | -209.71%-182.48M | -236.22%-173.64M | -141.42%-80.98M | -100.76%-1.4M | -9.57%166.34M | -27.09%127.47M | 630.83%195.49M |
Total composite income of minority owners | 88.84%-2.59M | 63.32%-4.51M | 63.26%-394.19K | -163.80%-25.44M | -192.97%-23.25M | -129.36%-12.29M | -102.80%-1.07M | 10.55%39.87M | -28.06%25.01M | 3,599.45%41.85M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Beijing Xinghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Beijing Xinghua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--